Product Image

Joint Health

Garden of Life Wobenzym N
4.8
ā˜… ā˜… ā˜… ā˜… ā˜…
(651 ratings)
Papain 180 mg
Rutin 150 mg
Bromelain 135 mg
Product Image
Score75
A broad protected proteolytic blend with useful rutin, weakened by duplicate label data, missing activity units, and poor value.
How scoring works
Quantity:100 Tablet(s) • (33 servings)
Goals:
Digestive Health

Score 75

A broad protected proteolytic blend with useful rutin, weakened by duplicate label data, missing activity units, and poor value.
How scoring works
$28.21($0.85 per serving)
iHerb
$ 28.21
Pure Formulas
$ 31.49
Report prices

Analysis

Pancreatin, papain, bromelain, trypsin, and chymotrypsin cover multiple protein-degrading pathways. Rutin is listed at 150 mg and fits the joint-health positioning.

Enzyme activity units are absent, and the label repeats 150 mg rutin under the compound and plant source. It is unclear whether those entries describe one amount or two, while protected delivery may delay release beyond the stomach.

The 33-serving bottle offers only moderate trial length and weak serving value. The formula makes more sense for systemic-joint positioning than as a straightforward meal-time digestive enzyme.

Who is it for
  • Adults seeking joint-oriented proteolytic enzymes
  • Users comfortable with animal-derived pancreatic enzymes
Best for
  • Systemic enzyme and rutin use
  • Broad protein-enzyme coverage

Pros

  • Five proteolytic enzymes
  • Includes rutin
  • Protected tablet delivery
  • Ingredient sources are partly identified

Cons

  • No activity units
  • Rutin amount is duplicated
  • Only 33 servings
  • Weak serving value

Warnings

  • Bromelain and papain may add to bleeding tendency with anticoagulant or antiplatelet medicines, especially around a procedure.
  • Pancreatin, trypsin, and chymotrypsin are animal-derived and may not fit vegetarian or certain religious dietary restrictions.

Nutrient quality

83 Highest impact

Enteric delivery and clearly named enzyme sources support systemic use, though activity units are missing. The supplied amounts support practical use for the intended purpose.

.

Ingredient transparency

78 High impact

The active weights are clearly listed, making the core formula possible to assess. Activity units, intake timing, and non-active ingredients are absent from the supplied data.

.

Customer satisfaction

69 High impact

The supplied average is very strong and the response volume is moderate. No detailed feedback is provided to assess recurring complaints or fit with the intended purpose.

.

Value for money

66 High impact

The serving may be economical, but missing enzyme activity limits confidence in value. A better standardized or more effectively dosed product would provide a stronger comparison.

.
Report analysis

Goals

Digestive Health
Impact
High effect
B Goal FitC+ Strength of SupportC CoverageD+ Formula Quality
Papain Ā· 180 mgBromelain Ā· 135 mg

Papain, bromelain, pancreatin, trypsin, and chymotrypsin provide broad protein-digesting enzyme coverage. The enteric coating protects the enzymes, but the joint-focused product may be intended for between-meal systemic use rather than digestion with food.

Ingredient weights are clear, yet no enzyme activity units show actual digestive potency. Bromelain and papain may increase bleeding risk with anticoagulant or antiplatelet medicines and may trigger reactions in people sensitive to pineapple or papaya.

Study evidence
Bromelain Supportive 2 studies
Papain Adverse 2 studies

Ingredients

IngredientAmount per serving
Pancreatin (Pancreas)
300 mg
Papain (Carica papaya)
180 mg
Bromelain (Ananas comosus)
135 mg
Trypsin (Pancreas)
72 mg
Chymotrypsin (Pancreas)
3 mg
Rutoside Trihydrate (Rutin, Sophora japonica)
150 mg
Gluten Free Adults 18–50 Dairy Free
Report overview
B- Active Ingredient Quality & BioavailabilityA+ Dose, Safety & Label TransparencyB+ Value

The papaya-derived papain is supplied at a high, clearly disclosed amount. Enteric-coated tablets support delivery beyond the stomach, but the label gives weight rather than standardized enzyme activity, so actual potency remains uncertain. The serving is relatively costly, though the high dose and specialized coating provide meaningful value support.

A+ Active Ingredient Quality & BioavailabilityC+ Dose, Safety & Label TransparencyD+ Value

The identified Sophora japonica source and trihydrate form provide strong ingredient transparency. Its disclosed rutin amount is modest and below the higher targeted range. The serving cost results in average value for the amount supplied.

D Active Ingredient Quality & BioavailabilityD+ Dose, Safety & Label TransparencyF Value

The enteric-coated tablet is well aligned with systemic joint use because it helps protect enzymes through the stomach. The formula supplies a meaningful amount of bromelain alongside other proteolytic enzymes, but its enzyme activity is not disclosed. Value is weak for the bromelain delivered, and the label details provided do not clarify whether it should be taken between meals.

Loading alternative details
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. The role of enzyme supplementation in digestive disorders.
    Roxas M Ā· Alternative medicine review : a journal of clinical therapeutic Ā· 2009
    Narrative reviewDigestive Health forBromelain
  2. Effects of bromelain supplementation on disease activity and quality of life in patients with ulcerative colitis: a randomized, triple-blind, placebo-controlled study.
    Delgarm P; Mokhtare M; Ebrahimi Daryani N; Abolghasemi J; Rahideh ST Ā· Scientific reports Ā· 2025
    Randomized trial70 participantsDigestive Health forBromelain
  3. The incidence and clinical implications of hypersensitivity to papain in an allergic population, confirmed by blinded oral challenge.
    Mansfield LE; Ting S; Haverly RW; Yoo TJ Ā· Annals of allergy Ā· 1985
    Clinical trial500 participantsDigestive Health forPapain
  4. Papaya preparation (CaricolĀ®) in digestive disorders
    Muss C, Mosgoeller W, Endler T Ā· Neuro Endocrinology Letters Ā· 2013
    Randomized trial76 participantsDigestive Health forPapain